Stock Score Valuation Add to Watchlist SCORE 47 NKTR: Nektar Therapeutics is a Sell AAPL chart by TradingView The current rating for NKTR is 47, which is 6% below its historic median rating of 50. This indicates higher risk than normal. The rating is currently showing a lower than normal reading, suggesting risk levels could be higher than normal and additional caution is advised.
Login Into Your Account
By clicking "Sign Up" you indicate that you have read and agree to the Terms of Service and Privacy Policy